Article
Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies.
Lancet (London, England) - 18 Jun 2016
Lettre Guillaume, Bauer Daniel E
Abstract excerpt
Sickle-cell disease affects millions of individuals worldwide, but the global incidence is concentrated in Africa. The burden of sickle-cell disease is expected to continue to rise over the coming decades, adding to stress on the health infrastructures of many countries. Although the molecular cause of sickle-cell disease has been known for more than half a century, treatment options remain greatly limited....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
